István Bodrogi - ODT Personal data sheet


	Login Forum Organisation officers member institutions resolutions (in Hung.) by-laws (in Hung.) regulations Doctoral program doctoral schools by institution by research field by number ceased working academic staff member by name by research topic archives thesis topic proposals by doctoral school by research field by research topic supervision of PhD students search students Theses defended by institution by research field by name by date by doctoral school Naturalized degrees by institution by research field by name by date Habilitation presentations by institution by branch of science by name Documents (all in Hung.) public documents news legal backgrounds guidelines Contacts contact details partners

Personal data sheet

Print preview

VALIDITY EXPIRED
personal data approved: 2011. I. 26.

Personal data

name	István Bodrogi
name of institution	Semmelweis University, Budapest
doctoral school	SE Doctoral School of Pathological Sciences (Academic staff member Az oktató a doktori iskola doktoranduszai számára oktat tantárgyat, és/vagy a doktori iskola megszavazta, hogy doktoranduszok számára kutatási témát írjon ki. ) SE Doctoral School of University Semmelweis (Academic staff member Az oktató a doktori iskola doktoranduszai számára oktat tantárgyat, és/vagy a doktori iskola megszavazta, hogy doktoranduszok számára kutatási témát írjon ki. )
the share of work in the different doctoral schools.	SE Doctoral School of University Semmelweis 100%

Contact details
E-mail address	bodrogioncol.hu
phone number	+36 1 224-8600/1521

Academic title
scientific degree, title	Ph.D.
year degree was obtained	1992
discipline to which degree belongs	clinical medicine
institution granting the degree	SE ÁOK Doktori Iskola (to be translated)

Employment
1969 -	Országos Onkológiai Intézet (research institute, not university) other (not specified) (nem nevesített)

Thesis topic supervisor
number of doctoral students supervised until now	1
number of students who fulfilled course requirements	0
students who obtained their degrees:
	Thesis topic proposals

Research
research area	Hormonal-, chemo-, immuno- and targeted therapy and genetic examination of urological tumors. Phase I-II-III. clinical pharmacology in solid tumors.
research field in which current research is conducted	clinical medicine

Publications

2010

de Bono JS, Oudard S, Ozguroglu M, Hansen S, Machiels JP, Kocak I, Gravis G, Bodrogi I, Mackenzie MJ, Shen L, Roessner M, Gupta S, Sartor AO: Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial, Lancet, 2010 Oct 2; 376(9747), pp. 1147-1154
type of document: Journal paper/Study paper
impact factor: 30.758
language: English
URL

2009

Horti J, Widmark A, Stenzl A, Federico MH, Abratt RP, Sanders N, Pover GM, Bodrogi I: A randomized double-blind, placebo-controlled phase II study of vandetanib plus docetaxel/prednisolone in patients with hormone-refractory prostate cancer, Cancer Biother Radiopharm 2009 Apr; 24(2), pp. 175-180
type of document: Journal paper/Article
impact factor: 1.443
language: English
URL

2009

Mai PL, Chen BE, Trucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Bodrogi I, Geczi L, Olah E, et al.: Younger age-at-diagnosis for familial malignant testicular germ cell tumor, Fam Cancer 2009;8(4), pp. 451-456
type of document: Journal paper/Article
impact factor: 2.189
language: English
URL

2008

J. Horti, E. Juhasz, Z. Monostori, K. Maeda, S. Eckhardt, I. Bodrogi: Phase I study of TZT-1021, a novel synthetic dolostatin 10 derivavite, for the treatment of patients with non-small cell lung cancer, Cancer Chemother. Pharmacol, pp. 173-180
type of document: Journal paper/Study paper
language: English

2006

K. Bíró, L. Noszek, P. Prekopp, K. Nagyiványi, L. Géczi, I. Gaudi, I. Bodrogi: Characteristics and risk factors of cisplatin induced ototoxicity in testicular cancer patients, detected by distorsion product otoacustic emission, Oncology, pp. 177-184
type of document: Journal paper/Study paper
impact factor: 2.252
language: English

2003

Géczi L., Gomez F., Bak M., Bodrogi I.: The incidence, prognosis, clinical and histological characteristics, treatment and outcome of patients with bilateral germ cell testicular cancer in Hungary, J. Cancer Ress Clin Oncol, pp. 309-315
type of document: Journal paper/Study paper
impact factor: 2.162
language: English

2001

Géczi L., Gomez Z., Horváth Zs., Bak M., Kisbenedek L., Bodrogi I.: Three-year result of the first education and early detection program for testicular cancer in Hungary, Oncology, pp. 228-234
type of document: Journal paper/Study paper
impact factor: 3.153
language: English

1998

Kaye S. B., Mead G., Fossa S., Cullen M., de Wit R., Bodrogi I. et al: Intensive Induction-Sequential Chemotherapy with BOP/VIP-B Compared with Treatment with BEP/EP for poor prognosis metastatic nonseminomatosus germ cell tumor: A Randomized Midecal Research Council/European Organisation for Research and Treatment of Cancer Study, J. Clin. Oncol., pp. 692-701
type of document: Journal paper/Study paper
impact factor: 7.878
language: English

1988

Bodrogi István, Baki M., Sinkovics I., Eckhardt S.: Ifosfamide chemotherapy of metastatic renal cell cancer, Semin Surg Oncol. 1988;4(2), pp. 95-96
type of document: Journal paper/Study paper
impact factor: 0.651
language: English
URL

1988

Bodrogi I., Baki M., Horti J., Liszka Gy., Ottó Sz., Hindy I., Sugár J., Eckhardt S., Karlinger K.: Nem seminoma típusú metasztatikus inoperabilis heredaganatok Vinblastin-Cisplatin-Bleomycin kezelése, Magyar Onkológia, pp. 258-268
type of document: Journal paper/Study paper
language: Hungarian

Number of independent citations to these publications:

Scientometric data

Publication list in MTMT is not accessible.

number of scientific publications that meet accreditation criteria:

number of scientific publications:

138

monographs and professional books:

monographs/books in which chapters/sections were contributed:

number of independent citations to scientific publications and creative works:

1758